Osteoporosis Current Events

Osteoporosis Current Events, Osteoporosis News Articles.
Sort By: Most Viewed | Most Recent
Page 1 of 25 | 1000 Results
3rd Baltic Congress of Osteoporosis to take place in Riga
Riga, Latvia will be the venue for the 3rd Baltic Congress of Osteoporosis which will take place on Sep. 3-4, 2010. The congress, to be held in English, is jointly organized by the Latvian Osteoporosis and Bone Metabolism Diseases Association, Lithuanian Osteoporosis Foundation, Lithuanian Association of Metabolic Bone Diseases and the Estonian Osteoporosis Society. (2010-05-18)

Cataracts linked to higher risks of osteoporosis and fracture
A new Journal of the American Geriatrics Society study has evaluated the potential impacts of cataracts and cataract surgery on the risks of osteoporosis and bone fractures. (2018-10-03)

Osteoporosis Patient Societies win US$ 126,000 in grants
At the International Osteoporosis Foundation World Wide Conference of Osteoporosis Patient Societies conference, held in Bangkok, Thailand, from September 27-30, 2005 eleven national osteoporosis societies won IOF grants valued at US$ 126,000. (2005-10-07)

What's the life expectancy of patients when they begin treatment for osteoporosis?
Despite reports that people with osteoporosis have an increased risk of dying prematurely, a new study has found that life expectancy of newly diagnosed and treated osteoporosis patients is in excess of 15 years in women below the age of 75 and in men below the age of 60. (2015-04-20)

Osteoporosis screening and treatment fall short for women with hip fractures
It's important to identify and treat osteoporosis following hip fracture, but a large study found low rates of assessment and treatment in postmenopausal women who had suffered a hip fracture. (2017-02-23)

The most important osteoporosis research, in a nutshell
Progress in Osteoporosis, the free online journal published by the International Osteoporosis Foundation, is the only open-access online resource that provides concise summaries of new osteoporosis research published in the preceding three to four months. (2009-05-18)

Osteoporosis: catching a time bomb among the elderly
In this study, Dr. Ernest Hajcsar and colleagues surveyed patients who had presented to Ontario fracture clinics with fractures associated with bone fragility. The authors sought to determine whether the patients had been treated for osteoporosis. (2000-10-02)

Study reveals disparities in osteoporosis treatment by sex and race/ethnicity
New research indicates that elderly men are significantly undertreated for osteoporosis compared with elderly women, and blacks have the lowest treatment rates among racial/ethnic groups. The findings are published in the Journal of Pharmaceutical Health Services Research. (2019-03-06)

Pharmacists can play key role in fight against osteoporosis: U of A study
University of Alberta researcher Nese Yuksel shows how pharmacists can help in the fight against osteoporosis, a disease that often goes undiagnosed. (2010-03-03)

World Congress on Osteoporosis 2010 -- IOFWCO-ECCEO10 to be held in Florence
We invite you to attend the joint Congress of the International Osteoporosis Foundation and the European Society of Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, to be held in Florence, Italy, May 5-8, 2010. Further information is available on the Congress Web site. (2009-01-15)

Secondary osteoporosis: More than what meets the eye!
An SGH study has revealed that considering all osteoporotic patients as having simple osteoporosis and treating all of them alike by putting them on potent long term medication without finding out the cause of their osteoporosis may be ineffective and in most cases downright harmful. (2012-10-09)

Thin men more vulnerable to osteoporosis and bone fractures than other older men
Obesity and weight increase leads to an increased risk of many chronic diseases, and the advice is therefore to maintain a stable healthy weight. Now, research shows that there may be disadvantages to being thin. Men who have low weight in middle age and who reduce their weight, increase the chance of osteoporosis and fracture. This is shown in data from the Norwegian Institute of Public Health and the University of Tromsø. The findings are now published in the American Journal of Epidemiology. (2008-09-18)

IOF announces Strong Bones Strong Women participants
The International Osteoporosis Foundation today announced the names of participants who will join Queen Rania of Jordan, IOF Patron, at the 2nd IOF Women Leaders Roundtable, to be held in Toronto, Canada on June 2, as part of the IOF World Congress on Osteoporosis. (2006-05-04)

Juliet Compston presented with IBMS John G. Haddad Jr. Award
Professor Juliet Compston, board member of the International Osteoporosis Foundation and the International Bone and Mineral Society, has been awarded the prestigious IBMS John G. Haddad Jr. Award. (2009-03-30)

Registration opens for Asia-Pacific's largest medical conference on osteoporosis
The International Osteoporosis Foundation, the Hong Kong Osteoporosis Foundation and the Osteoporosis Society of Hong Kong look forward to welcoming clinicians from around the world to Hong Kong for the IOF Regional 4th Asia-Pacific Osteoporosis Meeting. Online registration is now open. Lower rates are offered for early-bird registration and to delegates from WHO-designated low-income countries. (2013-04-10)

ESCEO-AMGEN Osteoporosis Fellowships awarded in Florence
Four ESCEO-AMGEN Osteoporosis Fellowships, each valued at $50,000, were awarded to young researchers working in Belgium, Canada, UK and Switzerland. (2010-05-06)

IOF World Congress on Osteoporosis
IOF World Congress on Osteoporosis, held every two years, is the only global congress dedicated specifically to all aspects of osteoporosis. All aspects of osteoporosis will be covered during the Congress, to be held from June 2-6, 2006 in Toronto. Visit (2005-10-19)

Patient societies from across the world share new strategies to tackle osteoporosis
Today, more than 130 osteoporosis patient society representatives gathered in Valencia, Spain, for the opening of the 13th IOF World Wide Conference of Osteoporosis Patient Societies. (2011-03-18)

Bulgarian society awarded 2011 IOF Linda Edwards Memorial Award
The Association Women without Osteoporosis of Bulgaria has been announced the winner of the 2011 IOF Linda Edwards Memorial Award. The award was presented by the International Osteoporosis Foundation (IOF) on the occasion of the IOF World Wide Conference of Osteoporosis Patient Societies in Valencia, Spain. (2011-03-20)

Advances in Skeletal Anabolic Agents for the Treatment of Osteoporosis: A scientific meeting
To learn about the exciting new directions in drug therapy for osteoporosis and other bone diseases, media are invited to attend Advances in Skeletal Anabolic Agents for the Treatment of Osteoporosis, a two-day meeting focusing on the current and future status of bone-building anabolic skeletal agents for osteoporosis treatment. (2004-05-18)

Once-yearly treatment significantly reduces bone fractures in women with postmenopausal osteoporosis
Phase III clinical trial shows effectiveness of once-yearly treatment for postmenopausal osteoporosis. (2007-05-02)

Men warned of osteoporosis problems by McMaster researcher
Osteoporosis isn't just a woman's problem. The bone-wasting disease can severely afflict men, too. (2007-01-30)

Research reveals how novel osteoporosis drug increases bone mass
Abaloparatide, a selective activator of the parathyroid hormone receptor, has recently been shown to reduce fractures in postmenopausal women with osteoporosis. Now new research shows that abaloparatide increases bone mass in rats whose ovaries have been removed by stimulating bone formation, without effects on bone resorption. (2016-10-19)

History of broken bones overlooked when treating osteoporosis
Women who need treatment for osteoporosis -- thinning of the bones -- may not be receiving it because their history of fractures is not being considered by physicians, according to a study done in part at the University of Alberta. (2005-02-24)

Abaloparatide benefits a wide range of postmenopausal women with osteoporosis
A recent analysis of results from a randomized controlled clinical trial indicates that abaloparatide-SC, a novel therapy for osteoporosis, provides consistent protection against bone fractures in postmenopausal women with osteoporosis regardless of their baseline bone density, age, and previous history of fracture. (2016-10-24)

Estrogen treatment with no side-effects in sight
Estrogen treatment for osteoporosis has often been associated with serious side-effects. Researchers at the Sahlgrenska Academy, University of Gothenburg, Sweden, have now, in mice, found a way of utilizing the positive effects of estrogen in mice so that only the skeleton is acted on, current research at the Academy shows. (2011-04-11)

Finnish researchers discover a new form of hereditary osteoporosis
Researchers at the University of Helsinki, Helsinki University Hospital (HUS) and Folkhälsan have identified a new gene whose variants cause hereditary childhood-onset osteoporosis. The gene defect was first found in two Finnish families. (2019-02-24)

WHO tool helps target bone treatment
Better-targeted, more cost-effective osteoporosis treatment could soon be a reality worldwide. A new method for determining more accurately at which point someone needs further diagnostic tests, or when immediate treatment is warranted, has been developed by the National Osteoporosis Guideline Group in the UK. (2008-12-03)

IOF applauds NOS on NICE Guidance appeal success and urges continued efforts
The International Osteoporosis Foundation has applauded the appeal success of the National Osteoporosis Society, in the matter of the National Institute for Health and Clinical Excellence's guidance for the primary and secondary prevention of osteoporotic fracture, and has called for continuing efforts to ensure that clinically appropriate and scientifically robust guidance is made available. (2007-12-18)

New osteoporosis therapy's dual effects on bone tissue
Sclerostin is a protein produced by osteocytes in the bone that inhibits bone formation. A recent analysis of results from a clinical trial reveals the beneficial effects of romosozumab, an antibody therapy that targets sclerostin, on bone tissue in postmenopausal women with osteoporosis. The findings are published in the Journal of Bone and Mineral Research. (2019-06-25)

IOF announces Tetra Pak's support of World Osteoporosis Day
The International Osteoporosis Foundation announced today that Tetra Pak, one of the world's leading food processing and packaging companies, will be a major partner for the IOF during 2006 in promoting awareness of how individuals can build strong bones and contribute to their bone health. Tetra Pak will also be a key partner in the World Osteoporosis Day (WOD) activities. (2006-04-05)

New link found between osteoporosis and coeliac disease
People with coeliac disease may develop osteoporosis because their immune system attacks their bone tissue, a new study has shown. (2009-10-07)

Do celebrities help sell new medicines?
Last month, Camilla Parker Bowles made her first big public speech on behalf of the National Osteoporosis Society to raise awareness of the bone condition. In this week's BMJ, journalist Ray Moynihan suggests that by spreading the word about osteoporosis, she is inadvertently helping to expand markets for new medicines. (2002-05-30)

ESCEO-AMGEN Fellowship awarded to Swedish and Argentinean researchers
Dr. Helena Johansson, Research fellow at the Centre for Bone Research at Sahlgrenska Academy, University of Gothenburg, Sweden, and Dr. Maria-Belen Zanchetta, Research fellow at the Instituto de Investigaciones Metabólicas in Buenos Aires, Argentina, have been announced the winners of the 2011 ESCEO-AMGEN Fellowship. (2011-03-24)

Loyola physician helps develop national guidelines for osteoporosis
The American Association of Clinical Endocrinologists has released new medical guidelines for the diagnosis and treatment of postmenopausal osteoporosis. Loyola physician Pauline Camacho, M.D., was part of a committee that developed the guidelines to manage this major public health issue. (2011-01-24)

Analysis examines link between bone turnover markers and fracture risk in osteoporosis trials
Pooled data from 14 osteoporosis clinical trials of anti-resorptive drugs indicate that patients who have reduced levels of two bone turnover markers during treatment have lower risks of later experiencing vertebral fractures. No bone turnover markers were significantly associated with non-vertebral or hip fracture risks, according to the Journal of Bone and Mineral Research analysis. (2018-01-10)

Impact of osteoporosis on the risk of dementia in almost 60,000 patients
Osteoporosis is estimated to affect 200 million women across the world. In Germany, the prevalence of this chronic disease among people aged 50 years and older is around 15 percent. In recent decades, several authors have analyzed the impact of osteoporosis on the risk of cognitive decline, but, most of these studies have been conducted outside Europe. (2018-08-20)

Bone societies from Australia, Colombia and Poland win grants for educational projects
The International Osteoporosis Foundation announced the winners of the 2011 IOF-AMGEN/GSK Health Professionals Awareness Grants on March 20th at the IOF Worldwide Conference of Osteoporosis Patient Societies in Valencia. The Grants, awarded to societies from Australia, Colombia and Poland, aim to support innovative projects by IOF member societies that focus on improving knowledge of osteoporosis among clinicians and allied health professionals. (2011-03-20)

Australia to host IOF Regionals -- 2nd Asia-Pacific Osteoporosis and Bone Meeting
IOF announces the 2nd Asia-Pacific Osteoporosis and Bone Meeting, to be held in conjunction with the Australian & New Zealand Bone & Mineral Society Annual Scientific Meeting and with the Japanese Bone and Mineral Research Society, from Sept. 4-8, 2011, in Queensland. The meeting will provide current information about the clinical management of osteoporosis, bone metabolism and basic bone science, as well as provide an opportunity to showcase regional research in an international context. (2011-02-17)

Obesity hormone adiponectin increases the risk of osteoporosis in the elderly
While obesity is a well-known cause of cardiovascular disease, research from the Sahlgrenska Academy at the University of Gothenburg, Sweden, has now revealed that the body's obesity hormones - adiponectin - are also linked to osteoporosis and an increased risk of fractures. (2011-11-01)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.